Gastroenterologist compensation has continued to rise in the last several years, while burnout has declined. Here are 10 notes on the GI workforce in 2024:
Category: Gastroenterology and Endoscopy
Next-generation CRC test earns FDA approval
The FDA has approved the Cologuard Plus test, a next-generation, multitarget stool DNA test approved for patients at an average risk for colorectal cancer.
No link between antibiotics, CRC in younger patients: Study: 10 things to know
A recent study by Oakland, Calif.-based Kaiser Permanente found that antibiotics use is unlikely to be a factor in the increase in CRC diagnosis in adults under 50.
More young patients getting colonoscopies: 7 things to know
In 2021, an advisory panel lowered the recommended age for when people should begin colon cancer screenings from 50 to 45. According to new data, there has since been a small but significant increase in screenings among younger people, according to an …
Interventional endoscopy leader joins NYU Langone
Nikhil Kumta, MD, a distinguished leader in the field of advanced endoscopy, has been named chief of endoscopy at Tisch Hospital and Kimmel Pavilion in New York City.
UCLA receives grant to boost CRC screenings in underserved areas
Researchers from UCLA Health’s Jonsson Comprehensive Cancer Center received a $3 million grant from the National Institutes of Health to enhance follow-up care after colorectal cancer screenings in underserved populations.
Robotic surgery better for colorectal cancer patients: 5 things to know
A new study, published in the Journal of Robotic Surgery, shows that robotic surgery provides an advantage for patients over traditional laparoscopic approaches to colorectal resections.
GI prescription provider renews Medicaid contract
RedHill Biopharma, a specialty biopharmaceutical company with a focus on developing treatments for the bacterial infection H. pylori, has renewed its contract with Medi-Cal, California’s Medicaid healthcare program.
Early anti-TNF treatment linked to Crohn's remission: Study
A multicenter prospective cohort study of patients with Crohn’s disease found that patients who received high concentrations of anti-tumor necrosis factor therapy were linked to a greater probability of sustained remission, Medscape Medical News report…
Bariatric surgeon to pay $45K to settle false claims allegations
A physician who formerly worked at Steward Easton (Pa.) Hospital has agreed to pay $45,000 plus interest to resolve allegations that he submitted false claims to Medicaid and Medicare by improperly billing esophagogastroduodenoscopies.
